StockData
Dolby Laboratories, Inc. logo

Dolby Laboratories, Inc. (DLB) stock

DLBNYSEPatent Owners & LessorsFiscal year ends September 27
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Sep 25, 2026Last filing: 10-K on Nov 17, 2026Score 21/3017% below fair value
$56.77−2.05 (-3.49%)

Close on Nov 18, 2026Market cap $5.32BP/E 21.0Yield 2.54%

Dolby Laboratories operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Dolby Laboratories's operating income for the twelve months ending Sep 25, 2026 was $303.99M, up 14.7% year over year. For fiscal 2026 it was $303.99M, up 14.7% from the year before. Over ten years it grew 2.7% a year on average. The highest annual figure on record is $429.73M in fiscal 2011.

Annual operating income

PeriodPeriod endValueChange
FY2026Sep 25, 2026$303.99M+14.7%
FY2025Sep 26, 2025$264.96M+2.6%
FY2024Sep 27, 2024$258.33M+19.7%
FY2023Sep 29, 2023$215.75M+4.4%
FY2022Sep 30, 2022$206.61M-40.0%
FY2021Sep 24, 2021$344.39M+57.4%
FY2020Sep 25, 2020$218.74M-14.9%
FY2019Sep 27, 2019$257.08M+40.1%
FY2018Sep 28, 2018$183.51M-25.7%
FY2017Sep 29, 2017$247.13M+6.6%
FY2016Sep 30, 2016$231.80M+8.7%
FY2015Sep 25, 2015$213.23M-22.1%
FY2014Sep 26, 2014$273.72M+11.6%
FY2013Sep 27, 2013$245.26M-32.2%
FY2012Sep 28, 2012$361.99M-15.8%
FY2011Sep 30, 2011$429.73M+0.1%
FY2010Sep 24, 2010$429.38M+18.1%
FY2009Sep 25, 2009$363.67M+26.8%
FY2008Sep 26, 2008$286.78M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ3 2026Sep 25, 2026$94.57M+218.7%
Q3 FY2026CQ2 2026Jun 26, 2026$34.32M-28.0%
Q2 FY2026CQ1 2026Mar 27, 2026$112.95M+4.8%
Q1 FY2026CQ4 2025Dec 26, 2025$62.16M-22.2%
Q4 FY2025CQ3 2025Sep 26, 2025$29.68M-36.0%
Q3 FY2025CQ2 2025Jun 27, 2025$47.64M+29.5%
Q2 FY2025CQ1 2025Mar 28, 2025$107.76M-1.1%
Q1 FY2025CQ4 2024Dec 27, 2024$79.88M+20.6%
Q4 FY2024CQ3 2024Sep 27, 2024$46.35M–
Q3 FY2024CQ2 2024Jun 28, 2024$36.78M+130.8%
Q2 FY2024CQ1 2024Mar 29, 2024$108.97M-0.2%
Q1 FY2024CQ4 2023Dec 29, 2023$66.22M-29.6%
Q4 FY2023CQ3 2023Sep 29, 2023-$3.49M-112.9%
Q3 FY2023CQ2 2023Jun 30, 2023$15.94M-65.0%
Q2 FY2023CQ1 2023Mar 31, 2023$109.22M+152.0%
Q1 FY2023CQ4 2022Dec 30, 2022$94.09M+3.9%
Q4 FY2022CQ3 2022Sep 30, 2022$27.11M-32.8%
Q3 FY2022CQ2 2022Jul 1, 2022$45.57M-18.8%
Q2 FY2022CQ1 2022Apr 1, 2022$43.35M-47.9%
Q1 FY2022CQ4 2021Dec 31, 2021$90.58M-45.0%
Q4 FY2021CQ3 2021Sep 24, 2021$40.37M+34.2%
Q3 FY2021CQ2 2021Jun 25, 2021$56.09M+64.3%
Q2 FY2021CQ1 2021Mar 26, 2021$83.19M-21.5%
Q1 FY2021CQ4 2020Dec 25, 2020$164.75M+239.1%
Q4 FY2020CQ3 2020Sep 25, 2020$30.07M-41.3%
Q3 FY2020CQ2 2020Jun 26, 2020$34.14M-0.3%
Q2 FY2020CQ1 2020Mar 27, 2020$105.95M+2.9%
Q1 FY2020CQ4 2019Dec 27, 2019$48.59M-29.2%
Q4 FY2019CQ3 2019Sep 27, 2019$51.22M+308.0%
Q3 FY2019CQ2 2019Jun 28, 2019$34.26M–
Q2 FY2019CQ1 2019Mar 29, 2019$102.93M+21.7%
Q1 FY2019CQ4 2018Dec 28, 2018$68.67M-26.9%
Q4 FY2018CQ3 2018Sep 28, 2018$12.55M-42.5%
Q3 FY2018CQ2 2018Jun 29, 2018-$7.61M-107.9%
Q2 FY2018CQ1 2018Mar 30, 2018$84.60M+33.7%
Q1 FY2018CQ4 2017Dec 29, 2017$93.95M+42.2%
Q4 FY2017CQ3 2017Sep 29, 2017$21.85M–
Q3 FY2017CQ2 2017Jun 30, 2017$95.93M–
Q2 FY2017CQ1 2017Mar 31, 2017$63.28M–
Q1 FY2017CQ4 2016Dec 30, 2016$66.07M–

More Dolby Laboratories figures

See a number that looks wrong?